GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy

J Cell Mol Med

31 July Jul 2009 16 years ago
  • Gaipa G, Tilenni M, Straino S, Burba I, Zaccagnini G, Belotti D, Biagi E, Valentini M, Perseghin P, Parma M, Di Campli C, Biondi A, Capogrossi MC, Pompilio G, Pesce M.
QR Code